| Tag | Content |
|---|
EnhancerAtlas ID | HS105-05303 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr1:161500400-161501540 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161501184-161501202 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161501180-161501198 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161500746-161500756 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161501180-161501201 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 |
|
| | Number of super-enhancer constituents: 16 | ID | Coordinate | Tissue/cell |
| SE_04668 | chr1:161498891-161504488 | Brain_Anterior_Caudate | | SE_07207 | chr1:161498982-161504752 | Brain_Hippocampus_Middle_150 | | SE_09773 | chr1:161497742-161504419 | CD14 | | SE_12218 | chr1:161499699-161501650 | CD3 | | SE_12655 | chr1:161500190-161500727 | CD34_adult | | SE_12655 | chr1:161501069-161501187 | CD34_adult | | SE_12761 | chr1:161500307-161500650 | CD34_fetal | | SE_12761 | chr1:161501118-161501331 | CD34_fetal | | SE_13488 | chr1:161498207-161504412 | CD34_Primary_RO01536 | | SE_15045 | chr1:161497584-161504740 | CD4_Memory_Primary_7pool | | SE_16658 | chr1:161499691-161501924 | CD4_Naive_Primary_8pool | | SE_20033 | chr1:161499313-161501693 | CD56 | | SE_20739 | chr1:161496350-161504511 | CD8_Memory_7pool | | SE_22428 | chr1:161499172-161501885 | CD8_primiary | | SE_39937 | chr1:161499262-161501453 | K562 | | SE_53676 | chr1:161499218-161501513 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161500960 | 161501200 | | chr1 | 161500608 | 161500899 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161528 | chr1 | 161498591 | 161503308 |
|
Enhancer Sequence | CTAATCCTTA AGGCTCCATT TTCCCTGGCG ACTCTTCGAG CGCCCCTCTG CTTCTGTAGA 60
GGGGTCGAGC CATGTCAAGG TAGACCCTGT GTCGGCCCGT CTCCCTCGGA TCCTCCGCAC 120
CAATCACTGT TGCTGAATCC GACACCCGGC GGATCCAGTG CGGAGTCTCG AACAGCTGCG 180
GAGCTGGGAG CTACGGGACA TGAAGAGAGC GGGGTGGAAG AGAAGACGGC GGAGGAAAAT 240
CCCCCGGCGA TGCTCAACTG CGGCTTTCTC TCTCGGCTGT GAGCCGGCTC CGCCCTCCAG 300
CTTCCAGAGC CGGTGGCTTC TGCGTTCACC GCCCCGCGCC GTTTGCGGGG CGGGGCTGAT 360
TCATAAGAAT CGGTTCTCAC CAATGGAGGG CTTAGCTTGT TTAACCTCAG GATCATAAAC 420
AAAAGACACT GCTAGAACGG TCGGGAAAGT CATACGCTTT GCTTATCTTA TATATAGATA 480
TCTAAAACTC CAAACCGGGT ACGCGTTGGT GGTATAGTGG TGAGCATAGC TGCCTTCCAA 540
GCAGTTGACC CGGGTTCGAT TCCCGGCCAA CGCAAGGGTT TTTGTCTTTC CTTCTACGAA 600
AAACCTTTCT CAGTCAGAAC CTATAACGCG CTGTGTATCC GTTTTACGCC TCAACGAAGT 660
ATCCGTTTTA CGCTTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT 720
CTTTCCCCTG GCCTCTTTCT AAACCCAGGC GTTTTTTGAA GGGATTAAAT TCTGATGGTT 780
CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC 840
AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA 900
TTCGCTAGCC ACGCACTATT GAGCACGTGA ACTTGGCTAG TTTCTCTAAG AAACTGCATT 960
TTCAAATTTA GTCTTAGTAA ATAAATCAAT TGAAATAAAA TTAATAAGTG AAAATTTTAA 1020
AATGGATACT TAATAACTCA ACCATTGGAG AAGGTTTCAG TGCATTTGAA ACAACGTGGC 1080
TATTGAATCT ACTTTTTCAA TTGTAAATTT TATGAAATCT AAATACGGAT TTTTTTCCGA 1140
|
